Indian Journal of PsychiatryIndian Journal of Psychiatry
Home | About us | Current Issue | Archives | Ahead of Print | Submission | Instructions | Subscribe | Advertise | Contact | Login 
    Users online: 6229 Small font sizeDefault font sizeIncrease font size Print this article Email this article Bookmark this page
Read this article


    Article Cited by others


A comparative study on the safety and efficacy of naltrexone versus baclofen versus acamprosate in the management of alcohol dependence

Kumar Arun, Sharma Arvind, Bansal P D, Bahetra Mamta, Gill Harkamal K, Kumar Rakesh

Year : 2020| Volume: 62| Issue : 6 | Page no: 650-658

   This article has been cited by
1 Naltrexone for alcohol use disorder: Hepatic safety in patients with and without liver disease
Divya Ayyala, Thomas Bottyan, Christine Tien, Michael Pimienta, Jennie Yoo, Kelli Stager, Jose Luis Gonzalez, Andrew Stolz, Jennifer L. Dodge, Norah A. Terrault, Hyosun Han
Hepatology Communications. 2022;
[Pubmed]  [Google Scholar] [DOI]
2 Helpful or Harmful? The Therapeutic Potential of Medications with Varying Degrees of Abuse Liability in the Treatment of Substance Use Disorders
Bradford Martins, Will Rutland, Joao P. De Aquino, Benjamin L. Kazer, Melissa Funaro, Marc N. Potenza, Gustavo A. Angarita
Current Addiction Reports. 2022;
[Pubmed]  [Google Scholar] [DOI]
3 Acamprosate better than baclofen for alcohol use disorder in cirrhosis: fact or myth?
Suprabhat Giri, Sridhar Sundaram
European Journal of Gastroenterology & Hepatology. 2022; 34(6): 724
[Pubmed]  [Google Scholar] [DOI]
4 Targeting Unmet Clinical Needs in the Treatment of Alcohol Use Disorder
Falk W. Lohoff
Frontiers in Psychiatry. 2022; 13
[Pubmed]  [Google Scholar] [DOI]